Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2867-2876

  Chen, Grace L ^a   Lamirande, Elaine W ^a   Cheng, Xing ^b   Torres Velez, Fernando ^a   Orandle, Marlene ^a   Jin, Hong ^b   Kemble, George ^b   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; COLD ACCLIMATIZATION; CROSS REACTION; DISEASE CARRIER; FEMALE; FERRET; IMMUNOGENICITY; IMMUNOMODULATION; INFECTION SENSITIVITY; INFLUENZA A (H2N2); MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PHENOTYPE; PLASMID; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVERSE GENETICS; TEMPERATURE SENSITIVITY; VACCINATION; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA VACCINES; MICE; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; RESPIRATORY TRACT INFECTIONS; SEQUENCE ALIGNMENT; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 84896714729     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01829-13     Document Type: Article

References (25)

1. Wright PF, Neumann G, Kawaoka Y. 2007. Orthomyxoviruses, p 1691-1740. In Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 1. Lippincott Williams and Wilkins, Philadelphia, PA.
2. Potter CW. 1998. Chronicle of influenza pandemics, p 3-18. In Nicholson KG, Webster RG, Hay AJ (ed), Textbook of influenza. Blackwell Science Ltd., Oxford, United Kingdom.
3. Dowdle WR. 1999. Influenza A virus recycling revisited. Bull. World Health Organ. 77:820-828.
4. Nabel GJ, Wei CJ, Ledgerwood JE. 2011. Vaccinate for the next H2N2 pandemic now. Nature 471:157-158. http://dx.doi.org/10.1038/471157a.
5. Makarova NA, Kaverin NV, Krauss S, Senne D, Webster RG. 1999. Transmission of Eurasian avian H2 influenza virus to shorebirds in North America. J. Gen. Virol. 80:3167-3171.
6. Suss J, Schafer J, Sinnecker H, Webster RG. 1994. Influenza virus subtypes in aquatic birds of eastern Germany. Arch. Virol. 135:101-114. http://dx.doi.org/10.1007/BF01309768.
7. Jonassen CM, Handeland K. 2007. Avian influenza virus screening in wild waterfowl in Norway, 2005. Avian Dis. 51:425-428. http://dx.doi.org /10.1637/7555-033106R1.1.
8. Kishida N, Sakoda Y, Shiromoto M, Bai GR, Isoda N, Takada A, Laver G, Kida H. 2008. H2N5 influenza virus isolates from terns in Australia: genetic reassortants between those of the Eurasian and American lineages. Virus Genes 37:16-21. http://dx.doi.org/10.1007/s11262-008-0235-z.
9. Krauss S, Obert CA, Franks J, Walker D, Jones K, Seiler P, Niles L, Pryor SP, Obenauer JC, Naeve CW, Widjaja L, Webby RJ, Webster RG. 2007. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog. 3:e167. http://dx.doi.org/10 .1371/journal.ppat.0030167.
10. Kawaoka Y, Krauss S, Webster RG. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63:4603-4608.
11. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. 1978. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13-20. http://dx.doi.org/10.1016/0042-6822(78)90153-8.
12. Schafer JR, Kawaoka Y, Bean WJ, Suss J, Senne D, Webster RG. 1993. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194:781-788. http: //dx.doi.org/10.1006/viro.1993.1319.
13. Kaverin NV, Smirnov YA, Govorkova EA, Rudneva IA, Gitelman AK, Lipatov AS, Varich NL, Yamnikova SS, Makarova NV, Webster RG, Lvov DK. 2000. Cross-protectionandreassortment studies with avianH2influenza viruses. Arch. Virol. 145:1059-1066. http://dx.doi.org/10.1007/s007050070109.
14. Armerding D, Rossiter H, Ghazzouli I, Liehl E. 1982. Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J. Infect. Dis. 145:320-330. http://dx.doi.org/10.1093/infdis/145.3.320.
15. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M. 2000. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr. 136:168-175. http://dx.doi.org/10.1016/S0022-3476(00)70097-7.
16. Delem A. 1977. Protective efficacy of RIT 4025, a live attenuated influenza vaccine strain, and evaluation of heterotypic immunity to influenza A viruses in ferrets. J. Hyg. 79:203-208. http://dx.doi.org/10 .1017/S0022172400053006.
17. Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M. 1999. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 18:899-906. http://dx.doi.org /10.1016/S0264-410X(99)00334-5.
18. Chen GL, Lamirande EW, Jin H, Kemble G, Subbarao K. 2010. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398:109-114. http://dx.doi .org/10.1016/j.virol.2009.12.003.
19. Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K. 2013. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza Other Respir. Viruses 7:66-73. http://dx.doi.org/10.1111/j.1750-2659.2012.00350.x.
20. Chen GL, Lamirande EW, Yang CF, Jin H, Kemble G, Subbarao K. 2010. Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets. J. Virol. 84:7695-7702. http://dx.doi.org/10.1128/JVI.00511-10.
21. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
22. Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, Kemble G, Subbarao K. 2008. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology 378:123-132. http://dx.doi.org/10 .1016/j.virol.2008.05.021.
23. Jin H, Manetz S, Leininger J, Luke C, Subbarao K, Murphy B, Kemble G, Coelingh KL. 2007. Toxicological evaluation of live attenuated, coldadapted H5N1 vaccines in ferrets. Vaccine 25:8664-8672. http://dx.doi .org/10.1016/j.vaccine.2007.10.032.
24. Chen Z, Zhou H, Kim L, Jin H. 2012. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets. J. Virol. 86:2780-2786. http://dx.doi.org/10.1128/JVI.06219-11.
25. Ma W, Vincent AL, Gramer MR, Brockwell CB, Lager KM, Janke BH, Gauger PC, Patnayak DP, Webby RJ, Richt JA. 2007. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. U. S. A. 104:20949-20954. http://dx.doi.org/10.1073/pnas .0710286104.